JP2015518876A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015518876A5 JP2015518876A5 JP2015515606A JP2015515606A JP2015518876A5 JP 2015518876 A5 JP2015518876 A5 JP 2015518876A5 JP 2015515606 A JP2015515606 A JP 2015515606A JP 2015515606 A JP2015515606 A JP 2015515606A JP 2015518876 A5 JP2015518876 A5 JP 2015518876A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pharmaceutically acceptable
- methylimidazo
- diazaspiro
- nonan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261655177P | 2012-06-04 | 2012-06-04 | |
| US61/655,177 | 2012-06-04 | ||
| US201361812416P | 2013-04-16 | 2013-04-16 | |
| US61/812,416 | 2013-04-16 | ||
| PCT/IB2013/054177 WO2013182933A1 (en) | 2012-06-04 | 2013-05-21 | Use of ghrelin receptor inverse agonists or antagonists for treating sleep disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015518876A JP2015518876A (ja) | 2015-07-06 |
| JP2015518876A5 true JP2015518876A5 (https=) | 2016-07-07 |
| JP6165852B2 JP6165852B2 (ja) | 2017-07-19 |
Family
ID=48700662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015515606A Expired - Fee Related JP6165852B2 (ja) | 2012-06-04 | 2013-05-21 | 睡眠障害を治療するためのグレリン受容体逆アゴニストまたはアンタゴニストの使用 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9370516B2 (https=) |
| EP (1) | EP2854856B1 (https=) |
| JP (1) | JP6165852B2 (https=) |
| KR (1) | KR101708989B1 (https=) |
| CN (1) | CN104334193A (https=) |
| AU (1) | AU2013273263B2 (https=) |
| BR (1) | BR112014029577A2 (https=) |
| CA (1) | CA2874196C (https=) |
| ES (1) | ES2716303T3 (https=) |
| HK (1) | HK1202459A1 (https=) |
| IL (1) | IL235883A0 (https=) |
| MX (1) | MX2014014813A (https=) |
| RU (1) | RU2600895C2 (https=) |
| SG (1) | SG11201407387UA (https=) |
| WO (1) | WO2013182933A1 (https=) |
| ZA (1) | ZA201408672B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105175272A (zh) * | 2015-08-31 | 2015-12-23 | 吴玲 | 制备r-5-溴-1-氨基茚满的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9606805D0 (en) | 1996-03-30 | 1996-06-05 | Glaxo Wellcome Inc | Medicaments |
| US6414002B1 (en) | 1999-09-22 | 2002-07-02 | Bristol-Myers Squibb Company | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| JP4717444B2 (ja) * | 2002-12-20 | 2011-07-06 | ザ マクレーン ホスピタル コーポレーション | 睡眠／覚醒サイクルの正規化のための化合物 |
| US20050171132A1 (en) * | 2003-09-26 | 2005-08-04 | Zhili Xin | Diaminopyrimidine derivatives as selective growth hormone secrectgogue receptor (GHS-R) antagonists |
| US20090149512A1 (en) * | 2004-05-14 | 2009-06-11 | Novo Nordisk A/S | Use of Ghrelin Antagonists to the Treatment of Certain CNS Diseases |
| US20090253673A1 (en) * | 2006-07-12 | 2009-10-08 | Min Ge | Substituted Pyrazoles as Ghrelin Receptor Antagonists |
| US8309530B2 (en) * | 2009-02-04 | 2012-11-13 | Washington State University | Compositions and methods for modulating ghrelin-mediated conditions |
| DK2547679T3 (en) | 2010-03-19 | 2016-01-11 | Pfizer | 2,3 dihydro-1H-inden-1-yl-2,7-diazaspiro [3.6] nonane derivatives and their use as antagonists or inverse agonists of ghrelin receptor |
-
2013
- 2013-05-21 BR BR112014029577A patent/BR112014029577A2/pt active Search and Examination
- 2013-05-21 ES ES13732257T patent/ES2716303T3/es active Active
- 2013-05-21 EP EP13732257.4A patent/EP2854856B1/en not_active Not-in-force
- 2013-05-21 WO PCT/IB2013/054177 patent/WO2013182933A1/en not_active Ceased
- 2013-05-21 US US14/398,800 patent/US9370516B2/en active Active
- 2013-05-21 KR KR1020147034009A patent/KR101708989B1/ko not_active Expired - Fee Related
- 2013-05-21 AU AU2013273263A patent/AU2013273263B2/en not_active Ceased
- 2013-05-21 SG SG11201407387UA patent/SG11201407387UA/en unknown
- 2013-05-21 CA CA2874196A patent/CA2874196C/en not_active Expired - Fee Related
- 2013-05-21 HK HK15103243.2A patent/HK1202459A1/xx unknown
- 2013-05-21 MX MX2014014813A patent/MX2014014813A/es unknown
- 2013-05-21 JP JP2015515606A patent/JP6165852B2/ja not_active Expired - Fee Related
- 2013-05-21 RU RU2014146109/15A patent/RU2600895C2/ru not_active IP Right Cessation
- 2013-05-21 CN CN201380029429.7A patent/CN104334193A/zh active Pending
-
2014
- 2014-11-24 IL IL235883A patent/IL235883A0/en unknown
- 2014-11-25 ZA ZA2014/08672A patent/ZA201408672B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20220766T1 (hr) | Amidom-supstituirani heterociklički spojevi korisni kao modulatori il-12, il-23 i/ili ifn alfa odgovora | |
| MX377802B (es) | Metodos y composiciones para trastornos del sueño y otros trastornos. | |
| HRP20250119T1 (hr) | Kdm1a inhibitor i njegova primjena u terapiji | |
| CA2918938C (en) | Substituted aminopyrimidine compounds and methods of use | |
| PH12015502628A1 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of disease | |
| MX2015016344A (es) | Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades. | |
| JP2010529118A5 (https=) | ||
| CL2015000578A1 (es) | Compuesto n-(2-(6-fluoro-1-h-indol-3-il)etil)-3-(2,2,3,3-tetrafluoropropoxi)bencilamina o su sal, antagonista del receptor 5-ht6; composicion farmaceutica; uso en el tratamiento de la enfermedad de alzheimer. | |
| HRP20151399T1 (hr) | Kinazni inhibitor koji regulira signalni put apoptoze | |
| CL2013003051A1 (es) | Compuestos derivados de pirazolo (4.3-d) pirimidinas, inhibidores de quinasa; composicion farmaceutica; y uso para el tratamiento de enfermedades y trastornos del aparato respiratorio | |
| WO2014205389A8 (en) | Nuclear transport modulators and uses thereof | |
| HRP20250250T1 (hr) | Derivati 7‑benzil‑4‑(2‑metilbenzil)‑2,4,6,7,8,9‑heksahidroimidazo[1,2‑a]pirido[3,4‑e] pirimidin‑5(1h)‑ona, njihove soli i njihova upotreba u terapiji | |
| MX2015016421A (es) | Derivados de pirazolo-pirrolidin-4-ona como inhibidores de bet y su uso en el tratamiento de enfermedades. | |
| CL2014000395A1 (es) | Compuestos derivados de piridazinona sustituida; compuesto intermediario; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de la esquizofrenia, trastorno esquizoafectivo, trastornos cognitivos o dolor. | |
| GEP20257716B (en) | Condensed imidazole derivatives substituted by tertiary hydroxy groups as pi3k-gamma inhibitors | |
| RU2017105353A (ru) | Соединения | |
| HRP20120918T1 (hr) | Aminopirazolski spoj | |
| CL2015002606A1 (es) | Compuesto. | |
| HRP20171824T1 (hr) | (TIENO[2,3-b][1,5]BENZOKSAZEPIN-4-IL)PIPERAZIN-1-ILNI SPOJEVI S DVOJNOM AKTIVNOŠĆU INVERZNIH AGONISTA H1 I ANTAGONISTA 5-HT2A | |
| JP2015500223A5 (https=) | ||
| WO2015085909A8 (zh) | 一种具有腺苷受体拮抗活性的氨基嘧啶杂环化合物 | |
| NZ702513A (en) | Amorphous form of an akt inhibiting pyrimidinyl - cyclopentane compound, compositions and methods thereof | |
| HK1203852A1 (zh) | 具有激酶抑制活性的二苯基甲醇-吡唑衍生物及其用途 | |
| RU2019104946A (ru) | Применение производного хромона в качестве антагониста дофаминового рецептора d3 для лечения расстройства аутистического спектра | |
| DK2802319T3 (da) | Fastdosiskombinationsterapi for parkinsons sygdom |